Service Portfolio

Deeper knowledge,
wider-ranging experience

Our vast experience, gained both client-side and within strategy consulting, enables us to deliver value at the intersection of three key industry dynamics:

The ever increasing need to demonstrate economic value
Shrinking sources of clinical competitive advantage
Cutting-edge therapeutic innovation

With these dynamics in mind our work with clients encompasses the following key areas:

CROSS-PORTFOLIO STRATEGY

We help identify complex growth opportunities that can be leveraged to bring value across whole therapeutic categories in the mid-long term.

PORTFOLIO, LICENSING & DEVELOPMENT STRATEGY

We bring deep process experience and therapeutic area expertise to portfolio optimization and L&D analyses.

NEW PRODUCT STRATEGY

We bring support to a broad range of new product launches from orphan drugs to first in class therapeutic categories, by helping to tease out a broad range of competitive opportunities.

ESTABLISHED PRODUCTS & FRANCHISE STRATEGY

Identifying complex growth opportunities that can be leveraged to bring value across whole therapeutic categories in the mid-long term.

PRICING, REIMBURSEMENT & MARKET ACCESS

With deep knowledge in a broad range of payer environments, we provide smart approaches to maximising opportunities within complex product launches.

COMMERCIAL EXCELLENCE

We deploy our broad range of research, analysis and benchmarking skills to help identify organisational and technological value drivers.

INVESTMENT STRATEGY

Extending our deep biopharma and healthcare knowledge base, we work with the investment community such as Private Equity and Venture Capital to help shortlist and scrutinise a broad range of investment opportunities.